2024 |
10x Genomics Inc - Ordinary Shares - Class A
|
Chief Executive Officer and Director |
- |
- |
2023 |
10x Genomics Inc - Ordinary Shares - Class A
|
Chief Executive Officer and Director |
8.3 M |
-55.9 % |
2022 |
10x Genomics Inc - Ordinary Shares - Class A
|
Chief Executive Officer and Director |
18.8 M |
60.7 % |
2021 |
10x Genomics Inc - Ordinary Shares - Class A
|
- |
11.7 M |
7.5 % |
2021 |
10x Genomics Inc - Ordinary Shares - Class A
|
Chief Executive Officer and Director |
11.7 M |
7.5 % |
2020 |
10x Genomics Inc - Ordinary Shares - Class A
|
- |
10.9 M |
360.6 % |
2020 |
10x Genomics Inc - Ordinary Shares - Class A
|
- |
10.9 M |
360.6 % |
2020 |
10x Genomics Inc - Ordinary Shares - Class A
|
Chief Executive Officer and Director |
10.9 M |
360.6 % |
2019 |
10x Genomics Inc - Ordinary Shares - Class A
|
- |
2.4 M |
117.9 % |
2019 |
10x Genomics Inc - Ordinary Shares - Class A
|
- |
2.4 M |
117.9 % |
2019 |
10x Genomics Inc - Ordinary Shares - Class A
|
Chief Executive Officer and Director |
2.4 M |
117.9 % |
2018 |
10x Genomics Inc - Ordinary Shares - Class A
|
- |
1.1 M |
- |
2018 |
10x Genomics Inc - Ordinary Shares - Class A
|
- |
1.1 M |
- |
2018 |
10x Genomics Inc - Ordinary Shares - Class A
|
Chief Executive Officer and Director |
1.1 M |
- |